Cancer surgeon and scientist who leads research and innovation at The Ottawa Hospital and its research institute.
Rebecca Auer is Executive Vice-President, Research and Innovation at The Ottawa Hospital and a Senior Scientist in cancer research at the Ottawa Hospital Research Institute, the not-for-profit corporation that fulfils the hospital's research mission. A surgical oncologist, her research examines how surgery promotes metastasis through the coagulation and immune systems and tests perioperative interventions, including low molecular weight heparin trials in colorectal surgery patients and oncolytic vaccinia virus therapy for metastatic colorectal cancer. She has led multicentre trials funded by the Canadian Institutes of Health Research.
| Title | Journal | Year |
|---|---|---|
| A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients | Annals of Surgical Oncology | 2022 |
| Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery | Annals of Surgical Oncology | 2018 |
| Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity | Nature Medicine | 2015 |
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares Annals of surgical oncology and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, immunotherapy.
Shares the tags leadership, clinician-scientist, surgical-oncology.
Shares the tags leadership, clinician-scientist, immunotherapy.
Shares the tags leadership, clinician-scientist, surgical-oncology.
Shares Annals of surgical oncology and the tag leadership.